Saltar ao contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Title
Autor
Subject
Número de Clasificación
ISBN/ISSN
Tag
Buscar
Avanzado
I-123 imaging for the predicti...
Citar
Text this
Enviar este rexistro por email
Imprimir
Exportar rexistro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Permanent link
I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg
Detalles Bibliográficos
Main Authors:
Britton, K
,
Foley, R
,
Siddiqi, A
,
Jan, H
,
Canizales, A
,
Plowman, P
,
Grossman, AB
,
Monson, J
,
Besser, G
Formato:
Journal article
Publicado:
1999
Existencias
Descripción
Títulos similares
Staff View
Títulos similares
The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.
por: Ali, N, et al.
Publicado: (2006)
The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning.
por: Siddiqi, A, et al.
Publicado: (2001)
Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
por: Mukherjee, J, et al.
Publicado: (2001)
NMR-ON MEASUREMENTS OF I-123, I-124, I-131 IN NICKEL
por: Ohya, S, et al.
Publicado: (1992)
Prevalence of Thyroglobulin Antibody (TgAb) positivity in patients post treatment for differentiated thyroid carcinoma and verification of serum thyroglobulin measurements by thyroglobulin recovery test and TgAb assay
por: Kathiravelu, Kaameny, et al.
Publicado: (2022)